Vijesti
Vijesti
- 4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round
14:07 - GlobeNewswire - VYNE Therapeutics Announces Development Program for FMX114 Combination Topical Gel for Mild-to-Moderate Atopic Dermatitis
14:00 - GlobeNewswire - EG 427 announces €12 million Series A financing to advance its HSV-1 based gene therapy
14:00 - GlobeNewswire - First High-Plex Spatial Omics Workflow with Integrated Single-Cell Analysis Now Available
14:00 - GlobeNewswire - Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
14:00 - GlobeNewswire - SalioGen Therapeutics Announces Closing of $20 Million Series A Financing to Support Advancing a Novel Genome Engineering Platform for Non-Viral Gene Therapy
14:00 - GlobeNewswire - Selecta Biosciences to Participate in the H.C. Wainwright Global Life Sciences Conference
14:00 - GlobeNewswire - Claritas Pharmaceuticals (formerly Kalytera Therapeutics) to Focus on Development of R-107 as a Therapy for Vaccine-Resistant COVID-19, Influenza, and Other Viral Infections
13:30 - GlobeNewswire - Homology Medicines Regains Worldwide Rights to Ophthalmology Program Based on its In Vivo Nuclease-Free Gene Editing Platform
13:30 - GlobeNewswire - OpGen Wins Chinese NMPA Approval for the Curetis Unyvero System
13:30 - GlobeNewswire
u realnom vremenu